Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05761093

Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Prince of Wales Hospital

Shatin, Hong Kong

Location status: Recruiting

Location contact

Chi Fai NG, MD

CONTACT

[email protected]

3505 2625

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 18 years or older,
  • diagnosis of metastatic prostate cancer within 5 years,
  • able to read and write,
  • accepting and signing the informed consent

Exclusion criteria

  • if patients are unable to complete the survey by themselves due to physical or psychological reasons,
  • deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
  • deemed ineligible by treating physicians

Treatment and study plan

Primary outcomes

  1. Patient preferences for treatment attributes in prostate cancer from different stages of disease

    Time frame: 15 minutes (Once through survey)

    Derived from discrete choice experiment

  2. The Preference weighting from Physicians involved in the treatment of prostate cancer in term of risk/benefit attributes of treatment.

    Time frame: 15 minutes (Once through survey)

    Derived from discrete choice experiment.

Secondary outcomes

  1. To examine the effect of socio-economic status on preference weighing

    Time frame: 15 minutes (Once through survey)

    Derived from discrete choice experiment

  2. To examine the status of comorbidities on preference weighing

    Time frame: 15 minutes (Once through survey)

    Derived from discrete choice experiment

  3. To examine their willingness of trading off survival with improving QOL

    Time frame: 15 minutes (Once through survey

    Derived from discrete choice experiment

Study contacts

Contact information is provided by the study sponsor or research team.

Chi Fai NG, MD

CONTACT

[email protected]

35052625

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
Mar 9, 2023
Registry last updated
May 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.